Research Focus

Clinical Pharmacology

Area of Research

Adverse drug reactions and drug safety

• EKNZ, project-ID: 2019–00127, Modification of the Institute for Healthcare Improvement Medication Module Trigger Tool to enable its digital implementation in a Swiss university hospital, start date 2019
• EKNZ, project-ID: 2018-00066, A comparison of vitamin K antagonist- and non-vitamin K antagonist-associated gastrointestinal bleeding, start date 2018
• EKNZ, project-ID: 2017-02329, Autoimmune Adverse Drug Reactions to Checkpoint Inhibitors: A Single Centre Case - Control Study, start date 2018
• EKNZ, Req-2023-00115, Emergency care doctors` attitudes to Best Possible Medication History conducted by pharmacists in training, start date 2023
• EKNZ, Req-2023-00116, Emergency care nurses` attitudes to Best Possible Medication History conducted by pharmacists in training, start date 2023
• EKNZ, project-ID: 2022-02004, Hyponatriämie, start date 2022

National Collaborations

• Umfrage zur Sicherheitskultur 2023 in den fünf Universitätsspitälern, Universitäre Medizin Schweiz, 2022 – ongoing
• Predictors of length of stay, mortality and rehospitalization in COPD patients: a retrospective cohort study, University Centre of Internal Medicine, Cantonal Hospital Baselland, Liestal
• Is serum 25-hydroxyvitamin D level associated with severity of COVID-19? A retrospective study.University Centre of Internal Medicine, Cantonal Hospital Baselland, Liestal

International Collaborations

• Best tolerated dose of Pirfenidone in patients with Fibrosing Interstitial Lung disease. Prof. Dr P Chhajed, Lung care and sleep centre, Mumbai

• EKNZ, project-ID: 2021-00284, Validation of risk factors for metamizole-induced leucopenia, start date 2020
• EKNZ, project-ID: 2020-00345, A retrospective evaluation of vancomycin therapeutic drug monitoring at the University Hospital Basel, start date 2020
• not applicable, COPD CPRD, start date 2023
• not applicable, Trigger Tool use in clinical practice, start date 2023